Ardent Health Inc. (ARDT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Per the Roarable RQD rating, ARDT scores 69 out of 100 (letter grade C+; verdict label "Roarable Hold — Upper Neutral / Watch for Breakout"). The five pillars are: Fundamental Cash Engine 16/20 (ROIC 10.5%; FCF yield 0%), Whale 13F Flow 14/20 (institutional accumulation and options positioning), Insider Conviction 13/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 11/20 (beta 1.0; sector sensitivity), and Forensic Balance Sheet 15/20 (Altman Z 2.5; Piotroski F 7/9; Debt/Equity 0.84). The strongest pillar is the cash engine and balance-sheet forensics, which together support the upper-neutral framing. The weakest pillar is macro regime fit, indicating that the stock's behavior is tied to broader sector and market conditions rather than being independently driven. The FCF yield of 0% in the rating's fundamental pillar sits in tension with the positive reported FCF in the financials section, so an investor should verify how the yield is computed before weighting that pillar heavily. Valuation context from the market data (trailing P/E 12.8, forward P/E 11.9) is not directly scored by the RQD pillars. The rating reflects a "watch for breakout" stance rather than a directional buy or sell signal.

Per the SEC financials, revenue grew from $5409.5M (FY 2023) to $6324.3M (FY 2025), while net income declined from $210.3M (FY 2024) to $135.8M (FY 2025). Reported operating income is $0.0M in every period, so operating margin cannot be meaningfully assessed from this source. Per the market data, net margin is 2.1%, gross and operating margins are listed as 0%, and ROIC is 10.5%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 7/9, with Debt/Equity at 0.84. Cash moved from $556.8M to $709.6M and debt from $1085.8M to $1075.8M over FY 2024–FY 2025.

• Digital leadership transition: Several headlines reference a new digital chief and its potential effect on the stock (ARDT-rss-0, ARDT-rss-5).
• Momentum/valuation framing: One report describes the stock as gaining 43% year-to-date and as looking like a bargain (ARDT-rss-1), and another cites a roughly 4% undervaluation estimate (ARDT-rss-5). Both are third-party characterizations.
• Governance item (watch): A Globe and Mail report states that a former CEO termination was reclassified as "for cause" (ARDT-rss-4). This is flagged yellow in the source and warrants monitoring for any governance or legal follow-through.
• Estimates/positioning: A TradingView estimates page and a kalkine.ca piece cover market positioning (ARDT-rss-2, ARDT-rss-3), without specific quantified claims in the summaries provided.
• Proprietary signals: The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals.

Per the Butterfly Supply-Chain Graph, the supply chain is "NONE," with no butterfly links and no proprietary signals. Upstream suppliers, downstream customers, and cross-sector correlations are therefore not available in source data. Investors should note that the RQD macro-regime pillar (11/20, beta 1.0) indicates sensitivity to sector and market conditions, which is the principal second-order channel the data supports. Specific 2nd-order bottlenecks cannot be identified from the sources provided.

• What is the source of the 0% FCF yield in the RQD fundamental pillar, given positive reported FCF of $470.5M for FY 2025?
• Operating income is reported as $0.0M in all periods; what is the actual operating margin and profitability trajectory?
• What are the specifics and timing of the digital leadership change, and how does it bear on the cost or revenue base?
• What were the circumstances and any financial or legal consequences of the former CEO's termination for cause?
• What is the current institutional, insider, and analyst ownership profile, given that the holders and analyst sections contain no data?